Why the study?
Cardiac sarcoidosis is underdiagnosed, associated with significant morbidity and mortality, and remains challenging to diagnose due to the lack of sensitivity and specificity of any single diagnostic method.
This review highlights the challenges in diagnosing cardiac sarcoidosis and emphasizes the need for multimodality imaging.
Answers are grounded in this paper and cite their sources.
Supports multimodality imaging for suspected cardiac sarcoidosis; leaves open standardized diagnostic algorithms.
Cardiac sarcoidosis (CS) is a widely underdiagnosed yet clinically significant form of granulomatous myocarditis associated with significant morbidity and mortality. Clinical presentation ranges from silent cardiac involvement detected on imaging to cardiomyopathy or sudden cardiac death. Diagnosis of CS remains challenging due to the lack of sensitivity and specificity of any single diagnostic method, underscoring the importance of elevated clinical suspicion and the use of multimodality imaging to guide diagnosis and treatment. In this review, we discuss the epidemiology, pathogenesis, clinical features, and diagnosis of this clinically evading and enigmatic disease.
No takes yet. Share an insight, caveat, or question.
Mathai et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: